Impacting the lives of children diagnosed with rare diseases by funding research and offering scholarships for alternative therapy.


There are approximately 7,000 known rare diseases in the United States, with an estimated 25-30 million total Americans living with rare genetic diseases. While specific conditions can be isolated, the total number of people with an orphan disease is overwhelming.

With a variety of causes, rare diseases can stem from a genetic origin and can be a direct cause of changes in genes or chromosomes. Some believe these diseases can be passed from one generation to the next. In other cases, they occur randomly in a person who is the first in a family to be diagnosed. With so many rare diseases and few affected per disease type, there is no government funding. The cost of just one disease can run in the millions of dollars.

How are we going to raise that kind of money?


Gene Replacement Therapy is the answer and the cure for many children and adults living with an orphan diseases in the United States. The researchers are so close to having therapy for rare diseases. What slows up the process is money and politics. The pharmaceutical companies must charge enormous amounts to the patient because it is a one and done cure.

Are You In Need of Assistance?


Lucas John Foundation offers scholarships for families and parents in the  NICU. Scholarships for alternative therapies for special needs children that are not typically covered by insurance. Lucas John Foundation offers financial assistance to pay for these alternative therapies so every child with special care needs has the opportunity to thrive. Similar to alternative treatments and therapies, DNA testing is often not covered by insurance. This is crucial step in diagnosing most rare diseases; Lucas John Foundation has DNA testing scholarships to relieve families of the very high cost of getting their child diagnosed.


Our goal is to make as many resources available to families impacted by special needs and rare diseases. As a family, we know how expensive therapies can be. We understand the financial burden of prolonged hospital stays and caregiving expenses.

We want to make this an easy process. Fill out the form and we will present your request and needs before the board of directors for approval. They may approve all, part, or none of the applications depending on budget and request details. Be very specific about your exact needs, the cost, and as much detail as you can about your story. We do not offer cash awards. In order to protect the integrity of our organization, we will make the scholarship paid directly to the entity providing the therapy, treatment, or testing. We may provide gift certificates to families currently in the NICU or extended hospital stay.

Our Story:
Hi, I'm Lucas!

I was born with a rare genetic condition with no medical cure, Nonketotic hyperglycinemia, or NKH. This condition is SO rare that it's considered an "orphan disease,” this means it affects so few people in the world (500 for NKH), that there is little to no funding for research to cure it! You can learn more about my story here. NKH causes many challenges with development, seizures, autism, cerebral palsy, and CVI blindness. 

Research funds are left solely to the parents, and families of those affected, and cures do not run cheap! In fact, gene replacement therapy is the only real medical cure being researched for NKH, and the projected cost is three million dollars!

Would it be Crazy to Ask You to Donate $1.00?

Help Us Support Families During their Darkest Days

What Others are saying

In the news

Rare disease is Not so Rare. Rare diseases in the U.S. Affect 25–30 million

May 12, 2020

Rare diseases are by their very nature obscure and unknown, falling through the cracks when it comes to research budgets and treatment development. But now, a study has shown they are more common than we think. New research shows that rare diseases are not that rare. The United States classifies a rare disease as one…

Gene Therapy AAV-based COVID-19 vaccine

May 9, 2020

Luk Vandenberghe, a gene therapy researcher at Massachusetts Eye and Ear and at Harvard Medical School, is spearheading an effort to develop a COVID-19 vaccine that uses an adeno-associated viral (AAV) vector to deliver genetic instructions for the SARS-CoV-2 spike protein into human cells. AAV vectors are used in the two commercial gene therapies in…

Patient Trial of Gene Therapy

May 4, 2020

1st Patient Dosed in Trial of Gene Therapy, OTL-201, for Sanfilippo Type A Orchard Therapeutics announced the dosing of a first patient in a clinical trial evaluating its investigational cell-based gene therapy OTL-201 for Sanfilippo syndrome type A. OTL-201’s safety, tolerability, and efficacy is being investigated in the open-label, Phase 1/2 study (NCT04201405) taking place at Manchester University NHS Foundation Trust in the…

Southport Mum renews appeal for daughter with rare disorder

By lucasjohn | May 22, 2020

Submitted by Sarah Steel Having been featured in the Liverpool ECHO last year, Sarah Steel, a mother from Southport whose daughter, Isla, suffers from a rare metabolic disorder, is now renewing her daughter’s appeal in an effort to generate funding for scientists to explore gene therapy trials. In 2018, after discovering little Isla’s hands were twitching, Doctors…

Please “Like” and “Follow” us on Social Media!

Follow Us on TikTok!

free ebook

Movement is key to healing. You can receive this free ebook by signing up on the form below.

movement lesson ebook

* indicates required

As a non-profit, we rely on donations to fund and offer support to improve the quality of life for families in the NICU and children with RARE diseases. Lucas John Foundation is registered with the IRS as 501(c)3 (ID: 83-3683882) tax-exempt status.

AZ Nonprofit corporation established, January 19, 2019.